Company profile
Rho Capital Partners
Investors & Funds · New York, United States
About the company
Multi-stage venture capital firm investing across technology sectors. Managing Partner Mark Leschly began with a healthcare focus and has backed numerous biotechnology, pharmaceutical and medical-technology companies, including Anacor, Dendreon, Human Genome Sciences, MedImmune and Vanda.
Official links
Explore the full company profile
Explore company Access the complete profile and structured research in the Explorer with eligible account access.